The Trial Innovation Network (TIN) Liaison Team is one of the three key organizational partners of the CTSA Trial Innovation Network. The Trial Innovation Network (TIN) leverages the expertise, skills, and knowledge of the entire CTSA consortium to innovatively address crucial roadblocks in multi-site clinical trials and accelerate the translation of novel interventions into lifesaving therapies. The TIN liaison team is designed assist investigators to leverage local and national CTSA resources including MUSC’s Clinical Trial Design Center.
What are the Three Key Organizational Partners of the TIN?
The three key organization parts of the TIN are the Trial Innovation Centers (TICs), Recruitment Innovation Center (RIC) and Trial Innovation Network (TIN) liaison teams. The TICS are charged with coordinating and providing, innovative, high quality operational support for clinical trials. The RIC is focused on innovation and evidence based approaches to participate recruitment, engagement and retention. The TIN liaison team uses their expertise and knowledge at the local level to coordinate and develop action plans best suited for our researchers.
Why Contact the TIN Liaison Team?
The TIN liaison team allows investigators to focus on the research question by streamlining the multi-center study process. Investigators receive support from the local TIN liaison team throughout the submission and implementation process, and are able to leverage a broad range of expertise. The TIN liaison team is designed to work in partnership with other CTSA institutions. Contact the TIN liaison team to see what we can do for your research study.
How Do I Contact the TIN Liaison Team?
What Is the Clinical Trial Design Center?
Clinical Trial Design Center (CTDC) is led by Drs. Chimowitz and Palesch. The CTDC staff will meet with investigators to help design multi-site trials and consult on statistics and data management. Additionally, Drs. Chimowitz and Palesch and SCTR staff will advise investigators on how to navigate the agencies involved (e.g., NIH, CMS, FDA), interact with industry partners, and prepare the trial budget.
Kathleen Brady, M.D., Ph.D.
Marc Chimowitz, MBChB
Royce Sampson, MSN, RN, CRA
Liaison Team Staff
Amanda Cameron, MPH, CCRP, CPH
Point of Contact
Signe Denmark, MS, CCRP
Ryan Mulligan, MRA, MS, CCRP, CRA
Toni Mauney, BA, CCRP